Ozempic Drug
- All
- News
- Videos
- Web Stories
-
Can Weight-Loss Drugs Make You Fall Out Of Love? The Science Behind The Viral Ozempic Theory
- Monday March 9, 2026
- Lifestyle | Written by Dristi Sharma
As millions begin using weight-loss drugs, a new question is surfacing online and in medical discussions: could these medications also influence romantic desire or intimacy?
-
www.ndtv.com/lifestyle
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
- Thursday March 5, 2026
- Health | Written by Shreya Goswami
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
www.ndtv.com
-
These Foods Mimic GLP-1 Drugs And Help Slow Down Gastric Emptying
- Tuesday March 3, 2026
- Health | Written by Varsha Vats
Certain foods can naturally reduce appetite and slow down gastric emptying by stimulating the release of GLP-1 and other satiety hormones.
-
www.ndtv.com
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
- Friday February 27, 2026
- Health | Reported by Tanushka Dutta
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
www.ndtv.com
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
- Thursday February 26, 2026
- Health | Written by Varsha Vats
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
www.ndtv.com
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
- Thursday February 26, 2026
- Health | Written by Varsha Vats
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
www.ndtv.com
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
- Thursday February 26, 2026
- Health | Written by Shreya Goswami
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
www.ndtv.com
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
- Wednesday February 25, 2026
- India News | Edited by Nikhil Pandey
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
www.ndtv.com
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
- Wednesday February 25, 2026
- Health | Written by Shreya Goswami
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
www.ndtv.com
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
- Monday February 23, 2026
- Health | Reported by Tanushka Dutta, Edited by Debosmita Ghosh
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
www.ndtv.com
-
Can Weight-Loss Drugs Make You Fall Out Of Love? The Science Behind The Viral Ozempic Theory
- Monday March 9, 2026
- Lifestyle | Written by Dristi Sharma
As millions begin using weight-loss drugs, a new question is surfacing online and in medical discussions: could these medications also influence romantic desire or intimacy?
-
www.ndtv.com/lifestyle
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
- Thursday March 5, 2026
- Health | Written by Shreya Goswami
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
www.ndtv.com
-
These Foods Mimic GLP-1 Drugs And Help Slow Down Gastric Emptying
- Tuesday March 3, 2026
- Health | Written by Varsha Vats
Certain foods can naturally reduce appetite and slow down gastric emptying by stimulating the release of GLP-1 and other satiety hormones.
-
www.ndtv.com
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
- Friday February 27, 2026
- Health | Reported by Tanushka Dutta
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
www.ndtv.com
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
- Thursday February 26, 2026
- Health | Written by Varsha Vats
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
www.ndtv.com
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
- Thursday February 26, 2026
- Health | Written by Varsha Vats
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
www.ndtv.com
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
- Thursday February 26, 2026
- Health | Written by Shreya Goswami
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
www.ndtv.com
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
- Wednesday February 25, 2026
- India News | Edited by Nikhil Pandey
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
www.ndtv.com
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
- Wednesday February 25, 2026
- Health | Written by Shreya Goswami
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
www.ndtv.com
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
- Monday February 23, 2026
- Health | Reported by Tanushka Dutta, Edited by Debosmita Ghosh
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
www.ndtv.com